Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

1.

The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H.

N Engl J Med. 1999 Dec 9;341(24):1789-94.

PMID:
10588963
[PubMed - indexed for MEDLINE]
Free Article
2.

Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.

Poldermans D, Boersma E, Bax JJ, Thomson IR, Paelinck B, van de Ven LL, Scheffer MG, Trocino G, Vigna C, Baars HF, van Urk H, Roelandt JR; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Eur Heart J. 2001 Aug;22(15):1353-8.

PMID:
11465968
[PubMed - indexed for MEDLINE]
Free Article
3.

Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).

Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ, Thomson IR, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Ann Surg. 2009 Jun;249(6):921-6. doi: 10.1097/SLA.0b013e3181a77d00.

PMID:
19474688
[PubMed - indexed for MEDLINE]
4.

Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.

Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A.

Anesthesiology. 2007 Jul;107(1):33-44.

PMID:
17585213
[PubMed - indexed for MEDLINE]
5.

A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.

Kertai MD, Boersma E, Westerhout CM, Klein J, Van Urk H, Bax JJ, Roelandt JR, Poldermans D.

Eur J Vasc Endovasc Surg. 2004 Oct;28(4):343-52.

PMID:
15350554
[PubMed - indexed for MEDLINE]
6.

Reducing cardiac risk in noncardiac surgery.

Lee TH.

N Engl J Med. 1999 Dec 9;341(24):1838-40. No abstract available.

PMID:
10588971
[PubMed - indexed for MEDLINE]
7.

Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery.

Poldermans D, Arnese M, Fioretti PM, Boersma E, Thomson IR, Rambaldi R, van Urk H.

Circulation. 1997 Jan 7;95(1):53-8.

PMID:
8994416
[PubMed - indexed for MEDLINE]
Free Article
8.

Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease.

Dávila-Román VG, Waggoner AD, Sicard GA, Geltman EM, Schechtman KB, Pérez JE.

J Am Coll Cardiol. 1993 Mar 15;21(4):957-63.

PMID:
8450165
[PubMed - indexed for MEDLINE]
Free Article
9.

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.

Mangano DT, Layug EL, Wallace A, Tateo I.

N Engl J Med. 1996 Dec 5;335(23):1713-20. Erratum in: N Engl J Med 1997 Apr 3;336(14):1039.

PMID:
8929262
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).

Böhm M, Maack C, Wehrlen-Grandjean M, Erdmann E.

Z Kardiol. 2003 Aug;92(8):668-76.

PMID:
12955414
[PubMed - indexed for MEDLINE]
11.

Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery.

Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, el-Said EM, du Bois NA, Roelandt JR, van Urk H.

Circulation. 1993 May;87(5):1506-12.

PMID:
8491005
[PubMed - indexed for MEDLINE]
12.

The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.

Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C; Diabetic Postoperative Mortality and Morbidity group.

Am Heart J. 2004 Apr;147(4):677-83.

PMID:
15077084
[PubMed - indexed for MEDLINE]
13.

Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.

Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, van De Ven LL, van Urk H, Roelandt JR; DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiogrpahy).

JAMA. 2001 Apr 11;285(14):1865-73.

PMID:
11308400
[PubMed - indexed for MEDLINE]
14.

Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography.

Ballal RS, Kapadia S, Secknus MA, Rubin D, Arheart K, Marwick TH.

Am Heart J. 1999 Mar;137(3):469-75.

PMID:
10047628
[PubMed - indexed for MEDLINE]
15.

Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography.

Poldermans D, Arnese M, Fioretti PM, Salustri A, Boersma E, Thomson IR, Roelandt JR, van Urk H.

J Am Coll Cardiol. 1995 Sep;26(3):648-53.

PMID:
7642854
[PubMed - indexed for MEDLINE]
Free Article
16.

Bisoprolol prevents mortality and myocardial infarction after vascular surgery.

Dickerson LM, Carek PJ.

J Fam Pract. 2000 Mar;49(3):203-4. No abstract available.

PMID:
10735475
[PubMed - indexed for MEDLINE]
17.

Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.

Schouten O, Poldermans D, Visser L, Kertai MD, Klein J, van Urk H, Simoons ML, van de Ven LL, Vermeulen M, Bax JJ, Lameris TW, Boersma E.

Am Heart J. 2004 Dec;148(6):1047-52. No abstract available.

PMID:
15632892
[PubMed - indexed for MEDLINE]
18.

Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery.

Feringa HH, Bax JJ, Schouten O, Poldermans D.

Semin Cardiothorac Vasc Anesth. 2006 Mar;10(1):25-31.

PMID:
16703231
[PubMed - indexed for MEDLINE]
19.

High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.

Feringa HH, Bax JJ, Boersma E, Kertai MD, Meij SH, Galal W, Schouten O, Thomson IR, Klootwijk P, van Sambeek MR, Klein J, Poldermans D.

Circulation. 2006 Jul 4;114(1 Suppl):I344-9.

PMID:
16820598
[PubMed - indexed for MEDLINE]
Free Article
20.

Perioperative beta-blocker therapy and mortality after major noncardiac surgery.

Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM.

N Engl J Med. 2005 Jul 28;353(4):349-61.

PMID:
16049209
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk